Stereoselective synthesis from a process research perspective

Drug Discovery Today

Volumn 7, Issue 5, 2002, Pages 303-314

  Hillier, Michael C ^a   Reider, Paul J ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM DERIVATIVE; DRUG; ENDOTHELIN RECEPTOR; INDAN DERIVATIVE; INDANONE; MUSCARINIC RECEPTOR BLOCKING AGENT; PIPERIDINE DERIVATIVE; SUBSTANCE P; ANTIBIOTIC AGENT; CARBAPENEM; ENDOTHELIN RECEPTOR ANTAGONIST; ERTAPENEM; INDACRINONE; INDINAVIR; PIPERIDINE; SUBSTANCE P ANTAGONIST;

ANIMAL; CHEMISTRY; COMBINATORIAL CHEMISTRY; DRUG ANTAGONISM; HUMAN; REVIEW; STEREOISOMERISM; SYNTHESIS; BIOAVAILABILITY; CHIRALITY; DRUG SYNTHESIS; HYDROGENATION; ISOMER; MEDICAL RESEARCH; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHYLATION; NONHUMAN; PHASE TRANSITION; REDUCTION; REGULATORY MECHANISM; STEREOCHEMISTRY;

ANIMALS; CARBAPENEMS; COMBINATORIAL CHEMISTRY TECHNIQUES; HUMANS; INDANS; MUSCARINIC ANTAGONISTS; PHARMACEUTICAL PREPARATIONS; PIPERIDINES; RECEPTORS, ENDOTHELIN; STEREOISOMERISM; SUBSTANCE P; ANIMAL; HUMAN;

EID: 0036489215     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(01)02162-6     Document Type: Review

References (68)

1. Separation of enantiomers: Resolution
2. Stereoselectivity and affinity in molecular pharmacology
3. Synthesis of optically active compounds: A large scale perspective
4. Properties of stereoisomers. Stereoisomer discrimination
5. Chirality and drug hazards
6. Chiral drugs
7. The FDA perspective on the development of stereoisomers
8. The FDA perspective on manufacturing and control
9. FDA policy and regulation of stereoisomers: Paradigm shift and the future of safer, more effective drugs
10. Chiral pharmaceuticals
11. (Acylaryloxy)acetic acid diuretics. 2. (2-Alkyl-2-aryl-1-oxo-5-indanyloxy)acetic acids
12. Stereoselectivity in the disposition and metabolism of the uricosuric-diuretic agent, indacrinone, in rhesus monkeys
13. Ototoxicity of indacrinone is stereospecific
14. Efficient catalytic asymmetric alkylations. 1. Enantioselective synthesis of (+)-indacrinone via chiral phase-transfer catalysis
15. Efficient catalytic asymmetric alkylations. 3. A kinetic and mechanistic study of the enantioselective phase-transfer methylation of 6,7-dichloro-5-methoxy-2-phenyl-1-indanone
16. Chiral Michael addition: Methyl vinyl ketone addition catalyzed by cinchona alkaloid derivatives
17. Enantioselective Robinson annelations via phase-transfer catalysis
18. Cinchona alkaloids and their derivatives: Versatile catalysts and ligands in asymmetric synthesis
19. Preliminary findings on the role of neuropeptide suppression by topical agents in the management of rheumatoid arthritis
20. Neurokinin receptors
21. Sensory neuropeptides and the human lower airways: Present state and future directions
22. Involvement of neurokinin 1 and 2 receptors in viscerosensitive response to rectal distension in rats
23. Distinct mechanism for antidepressant activity by blockade of central substance P receptors
24. 2(S)-((3,5-Bis(trifluoromethyl)benzyl)-oxy)-3(S)-phenyl-4-((3-oxo-1,2, 4-triazol-5-yl)methyl)morpholine (1): A potent, orally active, morpholine-based human neurokinin-1 receptor antagonist
25. Structural optimization affording 2-(R)-(1-(R)-3,5-bis(trifluoromethyl)phenylethoxy)-3-(S)-(4-fluoro)phenyl-4- (3-oxo-1,2,4-triazol-5-yl)methylmorpholine, a potent, orally active, long-acting morpholine acetal human nk-1 receptor antagonist
26. Synthesis and reaction of optically active morpholinones
27. Synthesis of N-benzyl-3-(S)-(+)-(4-fluorophenyl)-1,4-oxazin-2-one via crystallisation induced asymmetric transformation
28. Thermodynamically controlled 1,3-asymmetric induction in an acyclic system - Equilibration of α-amino nitriles derived from α-alkylbenzylamines and aldehydes
29. Efficient conversion of nitriles to amides with basic hydrogen peroxide
30. Crystallization induced asymmetric transformation - Synthesis of D-p-hydroxyphenylglycine
31. Titanium-mediated carbonyl olefinations. 1. Methylenations of carbonyl compounds with dimethyltitanocene
32. An improved synthesis of dimethyltitanocene
33. Piperidine-ether based hnk1 antagonist 1: Determination of the relative and absolute stereochemical requirements
34. 3-Benzyloxy-2-phenylpiperidine nk1 antagonists: The influence of alpha methyl substitution
35. Asymmetric synthesis of (2S,3S)-3-hydroxy-2-phenylpiperidine via ring expansion
36. Enantioselective synthesis of 2,3-disubstituted piperidines from (S)-methylpyroglutamate
37. Asymmetric catalytic epoxidation of unfunctionalized olefins
38. Stereoselective double ring closing metathesis reactions in the synthesis of spirocyclic compounds
39. Stereocontrolled synthesis of epimeric 3-aryl-6-phenyl-1-oxa-7-azaspiro[4.5]decane nk-1 receptor antagonist precursor
40. A double ring closing metathesis reaction in the rapid, enantioselective synthesis of nk-1 receptor antagonists
41. Synthesis and applications of RuCl2(=CHR′)(PR3)2: The influence of the alkylidene moiety on metathesis activity
42. Total synthesis of thienamycin: A new approach from aspartic acid
43. Synthesis of an anti-methicillin-resistant Staphylococcus aureus (MRSA) carbapenem via stannatrane-mediated Stille coupling
44. Preparation of crystalline p-nitrobenzyl 2-hydroxymethyl carbapenem as a key intermediate for the anti-MRSA carbapenem L-786,392
45. Synthesis and properties of 2-(naphthosultamyl)methyl-carbapenems with potent anti-MRSA activity: Discovery of L-786,392
46. Efficient and practical synthesis of a potent anti-MRSA β-methyl-carbapenem containing a releasable side chain
47. TiCl4/Bu3N/(catalytic TMSOTf): Efficient agent for direct aldol addition and Claisen condensation
48. Highly diastereoselective reaction of a chiral, non-racemic amide enolate with (S)-glycidyl tosylate. Synthesis of the orally active HIV-1 protease inhibitor L-735,524
49. Applications of cis-1-amino-2-indanol in asymmetric synthesis
50. A catalytic enantioselective synthesis of the endothelin receptor antagonists SB-209670 and SB-217242. A base-catalyzed stereospecific formal 1,3-hydrogen transfer of a chiral 3-arylindenol
51. Stereoselective conjugate addition reactions of α,β-unsaturated tert-butyl esters with aryl lithium reagents
52. Practical asymmetric synthesis of an endothelin receptor antagonist
53. Diastereoselective conjugate addition with acetals, oxazolidines, and imidazolidines as chiral auxiliaries
54. Practical asymmetric synthesis of a selective endothelin a receptor (ETA) antagonist
55. The catalytic enantioselective construction of molecules with quaternary carbon centers
56. Synthesis of a muscarinic receptor antagonist via a diastereoselective Michael reaction, selective deoxyfluorination and aromatic metal-halogen exchange reaction
57. A potent, long-acting, orally active (2R)-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: A novel muscarinic M3 receptor antagonist with high selectivity for M3 over M2 receptors
58. Pre-clinical and clinical pharmacology of selective muscarinic M3 receptor antagonists
59. Characterization of muscarinic receptor subtypes in SO2-induced mucus hypersecretion in rat bronchitis model
60. Asymmetric synthesis for process research
61. Stereoselective synthesis of a new muscarinic M3 receptor antagonist, J-104129
62. J-104129, a novel muscarinic M3 receptor antagonist with high selectivity for M3 over M2 receptors